Evaluation of in vitro activity of quinupristin/dalfopristin and comparator antimicrobial agents against worldwide clinical trial and other laboratory isolates
- 29 May 1998
- journal article
- review article
- Published by Elsevier in The American Journal of Medicine
- Vol. 104 (5), 34S-42S
- https://doi.org/10.1016/s0002-9343(98)00153-3
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- The emergence of Staphylococcus aureus with reduced susceptibility to vancomycin in JapanThe American Journal of Medicine, 1998
- Rapid Increase of Resistance to Erythromycin and Clindamycin in Streptococcus pyogenes in Italy, 1993-1995Emerging Infectious Diseases, 1996
- Antibiotic resistance and serotypes of Streptococcus pneumoniae at Birmingham public health laboratory, 1989–94Journal of Infection, 1996
- Prevalence of antibiotic resistance and serotypes in pneumococci in England and Wales: results of observational surveys in 1990 and 1995BMJ, 1996
- High Incidence of Resistance to Multiple Antimicrobials in Clinical Isolates of Streptococcus pneumoniae from a University Hospital in KoreaClinical Infectious Diseases, 1995
- RP 59500: a proposed mechanism for its bactericidal activityJournal of Antimicrobial Chemotherapy, 1992
- The in-vitro activity of new streptogramins, RP 59500, RP 57669 and RP 54476, alone and in combinationJournal of Antimicrobial Chemotherapy, 1992
- In-vitro activity of streptogramin RP 59500 against staphylococci, including bactericidal kinetic studiesJournal of Antimicrobial Chemotherapy, 1992
- The molecular basis of the inhibitory activities of type A and type B synergimycins and related antibiotics on ribosomesJournal of Antimicrobial Chemotherapy, 1989
- Transferable vancomycin and teicoplanin resistance in Enterococcus faeciumAntimicrobial Agents and Chemotherapy, 1989